Bitget App
Trade smarter
Buy cryptoMarketsTradeFuturesEarnSquareMore

News

Stay up to date on the latest crypto trends with our expert, in-depth coverage.

banner
All
Crypto
Stocks
Commodities & Forex
Macro
Federal Reserve Lowers Interest Rates, Ends Balance Sheet Reduction
Federal Reserve Lowers Interest Rates, Ends Balance Sheet Reduction

The Federal Reserve cut rates by 25 bps to 3.75–4.00% and ended QT early, signaling cautious easing amid rising labor market risks.

BeInCrypto·2025/10/29 10:16
What To Expect From Solana Price In November 2025?
What To Expect From Solana Price In November 2025?

With $381 million in institutional inflows and easing holder sell pressure, Solana is positioned for a potential breakout above $213 as November 2025 begins.

BeInCrypto·2025/10/29 10:00
Airdrop Pre-launch Phase, Check Out This MetaMask Season One Points Interaction Guide
Airdrop Pre-launch Phase, Check Out This MetaMask Season One Points Interaction Guide

This MetaMask Rewards event will last for 90 days and will distribute over $30 million worth of $Linea tokens as rewards.

BlockBeats·2025/10/29 09:33
Six major AI "traders" ten-day showdown: Who can survive in a market with "no information asymmetry"?
Six major AI "traders" ten-day showdown: Who can survive in a market with "no information asymmetry"?

AI is shifting from being a "research tool" to becoming a "frontline trader." So, how do they think?

BlockBeats·2025/10/29 09:13
Financial Black Hole: Stablecoins Are Devouring Banks
Financial Black Hole: Stablecoins Are Devouring Banks

Stablecoins, acting as "narrow banks," are quietly absorbing liquidity and reshaping the global financial architecture.

BlockBeats·2025/10/29 09:13
$263 million political "war fund" in place, crypto industry ramps up for US midterm elections
$263 million political "war fund" in place, crypto industry ramps up for US midterm elections

This time, there are more super political action committees, and some have taken clearer stances in aligning with Republican candidates.

ForesightNews 速递·2025/10/29 09:04
What is the background of Pieverse, which caught the x402 trend just before Pre-TGE?
What is the background of Pieverse, which caught the x402 trend just before Pre-TGE?

Binance has teamed up with BNB Chain to support its top "flagship project."

ForesightNews 速递·2025/10/29 09:03
SOL ETF opens the floodgates—can Jito leverage this to ignite a Solana ecosystem rebound?
SOL ETF opens the floodgates—can Jito leverage this to ignite a Solana ecosystem rebound?

Although the Solana ETF has been launched, network revenue trends are declining. Jito is at the intersection of new capital inflows and microstructure improvements.

ForesightNews 速递·2025/10/29 09:03
Michael Saylor and Robert Kiyosaki Give End-of-2025 Bitcoin Price Prediction
Michael Saylor and Robert Kiyosaki Give End-of-2025 Bitcoin Price Prediction

Bitcoin advocates Michael Saylor and Robert Kiyosaki made bold year-end forecasts, expecting prices to double despite recent volatility and MicroStrategy’s stock drop.

BeInCrypto·2025/10/29 09:00
Flash
12:56
Spot Gold Drops $14 in Short-Term
Spot gold has fallen $14 in the short term, declining over 1.00% during the day, currently reported at $4133.10 per ounce. (Jin Shi)
12:51
Vivos (OTC market code: RDGL) has received Investigational Device Exemption (IDE) approval from the US Food and Drug Administration (FDA) and will initiate a human clinical feasibility study of its Radiogel® Precision Radionuclide Therapy™.
This approval marks a key step forward for the clinical application of this innovative therapy, allowing the company to begin initial safety and feasibility assessments in humans. The Radiogel® technology is designed to enable precise radiation treatment within tumors and is expected to provide a new treatment option for cancer patients. The approved clinical study will collect essential data to lay the foundation for larger-scale clinical trials in the future.
12:51
Anixa Biosciences announced that in its clinical trial of CAR-T cell therapy, no dose-limiting toxicities were observed up to the previously established 3x10⁶/kg dose level.
This positive safety data lays the foundation for further exploration of higher doses and demonstrates the potential of this therapy in terms of patient tolerability.
News